Close Menu

product launch

By Tony Fong
NEW YORK (GenomeWeb News) – Genetic test maker Pinpoint Genomics has moved into commercialization phase with the launch of its first product, a prognostic test for non-small cell lung cancer.

The UK firm which went public last month has developed an instrument about the size of a PC targeting laboratories, both small and large, that may not have the space for a conventional platform.

The real-time, single-molecule sequencing technology firm reported $270,000 in grant revenue for the quarter. Its CEO said during a conference call that the company has an order backlog of 44 PacBio RS systems.

Researchers participating in the Allen Institute for Brain Science's Human Brain Atlas project announced that they have generated gene expression and other data at 1,000 anatomical sites each for two human brains.

With the launch of the Ion Torrent platform, Life Technologies said that it will award $1 million each to winners who can use the technology to improve upon results achieved internally in the first phase of the Life Grand Challenges Contest.

The firm is nearing a market launch of the system, called the nanoAnalyzer 1000. The system is being developed for a variety of applications including genome assembly, structural variation analysis, and assessing DNA damage.


The first reported coronavirus cases in Europe and the US might not be related to the subsequent outbreaks in those areas, according to the New York Times.

According to NPR, there's a growing shortage of machines to run SARS-CoV-2 tests.

The Wall Street Journal and Kaiser Health News report that antibody testing for SARS-CoV-2 has led to further confusion.

In Nature this week: the largest known collection of human genetic variants, and more.